LRN | StrideNYSEConsumer StaplesCommon stock golden cross and death cross projections, cross tests and history

$75.05
-$0.66 (-0.87%)

Stride (LRN) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $75.05 vs 50 $81.08 / 200 $86.02
Projection
No cross projected
Test
No active test
Last cross
Death cross 23 Sep 2026 ยท projected 21 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $74.53 vs 50 $79.90 / 200 $83.56
Projection
No cross projected
Test
No active test
Last cross
Death cross 14 Jul 2026 bar 1 ยท projected 30 bars out ยท tested 3 bars

Cross history

24
crosses on record since 2017
11 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
week of 5 Oct 2026Death steepweekly14 bars outActive Cross Test
23 Sep 2026Death moderatedaily21 bars outNot tested
14 Jul 2026Death4-hour30 bars out3 bar cross test
29 Jun 2026Golden flatdaily20 bars out4 bar cross test
3 Mar 2026Golden4-hour29 bars out5 bar cross test

About LRN

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$56.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorConsumer Staples
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.